© 2016 Global Market Insights, Inc. USA. All Rights Reserved Fuel Cell Market size worth $25.5bn by 2024 Insulin Delivery Devices Market share research by applications and regions for : Global Market Insights Inc.

© 2016 Global Market Insights, Inc. USA. All Rights Reserved  U.S. insulin delivery devices market accounted for largest market share in 2016 owing to increasing awareness levels amongst the affected population. Increasing diabetic population and the availability of technologically advanced devices are the factors leading to the high market growth. Also, as per Canadian Diabetes Association, the prevalence of diabetes is increasing in Canada and it is projected to reach over 4 million by Forming a large patient base with diabetes and its growing incidence is likely to enhance the growth in the U.S. region for insulin delivery devices market during the forecast period.  India and China, are anticipated to witness significant growth during the forecast period due to the existence of a vast patient base suffering with diabetes and rising awareness of insulin delivery devices. In addition, large number of regional players are expanding their business by providing high-end products for diabetes care. Regional Analysis of Insulin Delivery Devices Market :

© 2016 Global Market Insights, Inc. USA. All Rights Reserved Application Analysis of Insulin Delivery Devices Market :  Insulin pens accounted for highest market share in 2016, owing to its benefits such as its user- friendly design, high adoption rate, and increasing acceptance amongst consumers. Rising focus of companies on product innovation should yield the high industry share. For example, Novo Nordisk launched a new device called NovoPen Echo in the U.S. It was the first device of its kind, with a half-unit dosage feature and memory function.  Homecare segment will continue to account for maximum market share during the forecast period. The significant factors resulting in substantial growth are growing adoption of insulin delivery devices and increasing awareness of diabetes care. Home usage of insulin devices saves additional visiting costs, clinic, or hospital fee, and waiting time. The developed devices including pens, pumps, and injectors, are small, highly portable, and give a comfort of using them anywhere and anytime. Therefore, better access to such delivery devices and their developed ease of usage has enabled insulin users opt for self-care diabetes management options.

© 2016 Global Market Insights, Inc. USA. All Rights Reserved  Companies operating in insulin delivery devices market include Novo Nordisk (Subsidiary of Novo A/S), Tandem Diabetes Care, Sanofi, Medtronic, Valeritas, Becton, Dickinson and Company, Eli Lilly, F. Hoffmann-La Roche, Ypsomed, Owen Mumford, Animas, Insulet Corporation, Asante Solutions (Now Bigfoot Biomedical), Abbott Laboratories, Biocon Ltd., Antares Pharma, Bioject Medical Technologies, Injex - Equidyne Systems, Tonghua Dongbao Pharmaceutical, Shanghai Fosun Pharmaceutical. Competitive Market Share of Insulin Delivery Devices Market :

© 2016 Global Market Insights, Inc. USA. All Rights Reserved Browse Full Market Research Report On Insulin Delivery Devices Request for an in-depth table of contents for this Gaming Console Market

© 2016 Global Market Insights, Inc. USA. All Rights Reserved Stay In Touch Website: Social Media: